Siga Technologies (United States)
SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Siga Technologies (United States), United States, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
64%
Total
Publications
150
Total Open
Publications
96
Total
Citations
7.2K
Open Access
Percentage
64%
Total
Publications
150
Total Open
Publications
96
Total
Citations
7.2K
Breakdown
Publisher Open
16%
Both
36%
Other Platform Open
12%
Closed
36%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 54%
42
Hybrid 10%
8
No Guarantees 36%
28
Other Platform Open
Domain 91%
68
Institution 19%
14
Preprint 5%
4
Other Internet 3%
2
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 69 |
doaj.org OAI-PMH Repository | Institution | 9 |
Office of Scientific and Technical Information | Institution | 2 |
Europe PMC | Domain | 2 |
DOI | Other Internet | 2 |
bioRxiv | Preprint | 2 |
Utah State University | Institution | 1 |
University of Oxford | Institution | 1 |
Universitat Autònoma de Barcelona | Institution | 1 |
umt.edu OAI-PMH Repository | Institution | 1 |